Cpda-1 Solution
Product Images NDC 0942-9398

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Cpda-1 (NDC 0942-9398). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fenwal, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

4r3622cuploading1 (4r3622cuploading1)

4r3622cuploading1 (4r3622cuploading1)
This text provides instructions for loading centrifuge cups with containers and satellite containers. It also recommends using a SorvalĀ® Blood Bag set to fill excess space in the cup to prevent breakage. However, without proper formatting and visuals, it may be difficult to fully understand the instructions.*
FDA Label Image

4r3622cuploading2 (4r3622cuploading2)

4r3622cuploading2 (4r3622cuploading2)
This text is a combination of product descriptions and instructions from Fresenius Kabi AG, a company that creates medical devices and drugs. The text mentions a guide for loading cups, which applies to non-filter BPU configurations. The stacking order and methods may vary based on equipment and standard operating procedures for each facility. The company secures primary containers inside satellitic containers with the cannula; the specifications may vary based on centrifuge equipment. The text includes a reference to Sorvallis, a trademark of Thermo Fisher Scientific LLC.*
FDA Label Image

4r3622figures (4r3622figures)

FDA Label Image

4r3622packlbl (4r3622lbl)

4r3622packlbl (4r3622lbl)
This is a description of Fenwal Blood-Pack Units that contain Anticoagulant Citrate Phosphate Dextrose Adenine Solution, USP (CPDA-1) which is used for the collection and processing of 450 mL of blood. The unit consists of a primary container with 63 . of CPDA-1 solution containing 2 g Dexiroge monchygrate USP, 1.66 g Sodium Cirate dihycrate) USP, 188 mg Ciic Acd anycrous) USP, 140 mg Mancbasic odium Phesphate monohydrate) USP and 17.3 mo Aderine USP. It may have been adjusted with sodium hydroxide and comes in an empty 400 . Transter Pack container. It is sterile, no-pyrogenic, and is for single-use only. It is stored at Controlled Room Temperature and protected from freezing and excessive heat. See instructions for use.*
FDA Label Image

4r3622sym (4r3622symbols)

4r3622sym (4r3622symbols)
Symbols with Definitions: Caution, consult instructions for use. Sterilized by steam. Sterile fluid path. Non-pyrogenic fluid path. Do not reuse. Do not vent. This way up. Lot code.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.